Infectocillin Saft (Phenoxymethylpenicillin Potassium)

• Infectocillin Saft is a penicillin antibiotic that targets susceptible bacterial pathogens in various infections.
• Streptococcal pharyngitis: effective in treating confirmed group A streptococcal throat infection.
• Acute otitis media: used to eradicate susceptible bacterial pathogens in middle‑ear infection.
• Skin and soft tissue infections (e.g., impetigo): helps clear mild bacterial skin infections.
• Respiratory tract infections: employed for mild to moderate bacterial bronchitis and sinusitis.

• Phenoxymethylpenicillin potassium inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, which blocks the transpeptidation step of peptidoglycan cross‑linking. This disruption leads to weakened cell walls, osmotic instability and ultimately bacterial lysis of susceptible organisms.

Phenoxymethylpenicillin potassium may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Vomiting: occasional emesis after dosing.
• Diarrhea: loose stools, often self‑limiting.
• Abdominal pain: cramping or discomfort.
• Rash: transient skin erythema.
• Taste disturbance: altered taste perception.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction.
• Stevens‑Johnson syndrome: rare severe skin eruption.
• Serum‑sickness‑like reaction: fever, arthralgia, rash.
• Clostridioides difficile‑associated colitis: severe diarrhea.
• Hemolytic anemia: destruction of red blood cells.
• Severe skin reactions: toxic epidermal necrolysis.

• When prescribing Infectocillin Saft, consider the following precautions to ensure safe use.
• Allergy assessment: confirm no known hypersensitivity to penicillins before initiating therapy.
• Renal impairment: adjust dosage in patients with severe renal dysfunction.
• Age considerations: use with caution in neonates and the elderly due to altered pharmacokinetics.
• Concurrent antibiotics: avoid overlapping use with other beta‑lactam agents to reduce resistance risk.
• Pregnancy and lactation: discuss potential risks with the prescriber as safety data are limited.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Phenoxymethylpenicillin potassium can interact with several medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Probenecid: may increase penicillin plasma concentrations, raising toxicity risk.
• Methotrexate: concurrent use can enhance methotrexate toxicity.
• Oral contraceptives: penicillins may reduce hormonal contraceptive effectiveness.

Moderate Interactions (Monitor Closely)

• Warfarin: may potentiate anticoagulant effect, requiring INR monitoring.
• Allopurinol: increased risk of skin rash when combined.
• Bacteriostatic antibiotics (e.g., tetracyclines, chloramphenicol): may antagonize the bactericidal action of penicillin.